These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9349472

  • 1. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.
    Watkins BA, Crowley R, Davis AE, Louie AT, Reitz MS.
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2513-22. PubMed ID: 9349472
    [Abstract] [Full Text] [Related]

  • 2. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ, Kedar P, Pope JH.
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [Abstract] [Full Text] [Related]

  • 3. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K, Pretzer E, Celada F, Düzgüneş N.
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites.
    Cornelissen M, Hogervorst E, Zorgdrager F, Hartman S, Goudsmit J.
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1169-75. PubMed ID: 8573372
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
    Kinomoto M, Mukai T, Li YG, Iwabu Y, Warachit J, Palacios JA, Ibrahim MS, Tsuji S, Goto T, Ikuta K.
    Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
    [Abstract] [Full Text] [Related]

  • 12. CD4 activation of HIV fusion.
    Sattentau QJ.
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [Abstract] [Full Text] [Related]

  • 13. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
    Cornelissen M, Mulder-Kampinga G, Veenstra J, Zorgdrager F, Kuiken C, Hartman S, Dekker J, van der Hoek L, Sol C, Coutinho R.
    J Virol; 1995 Mar; 69(3):1810-8. PubMed ID: 7853521
    [Abstract] [Full Text] [Related]

  • 14. HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS.
    Ida S, Gatanaga H, Shioda T, Nagai Y, Kobayashi N, Shimada K, Kimura S, Iwamoto A, Oka S.
    AIDS Res Hum Retroviruses; 1997 Dec 10; 13(18):1597-609. PubMed ID: 9430252
    [Abstract] [Full Text] [Related]

  • 15. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R, Decroly E, Kieny MP, Fenouillet E.
    Virology; 2000 Jul 20; 273(1):169-77. PubMed ID: 10891419
    [Abstract] [Full Text] [Related]

  • 16. Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages.
    Aquino-De Jesus MJ, Anders C, Miller G, Sleasman JW, Goodenow MM, Andiman WA.
    J Med Virol; 2000 Jun 20; 61(2):171-80. PubMed ID: 10797371
    [Abstract] [Full Text] [Related]

  • 17. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein.
    Milich L, Margolin BH, Swanstrom R.
    Virology; 1997 Dec 08; 239(1):108-18. PubMed ID: 9426451
    [Abstract] [Full Text] [Related]

  • 18. Coexpression of a nonsyncytium inducer HIV-1 glycoprotein inhibits syncytium formation by another HIV-1 Env protein.
    Li YY, O'Donnell MA, Perez LG.
    Virology; 1996 Jan 15; 215(2):197-202. PubMed ID: 8560767
    [Abstract] [Full Text] [Related]

  • 19. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A, Voss G, Hunsmann G.
    Virology; 1993 May 15; 194(1):37-43. PubMed ID: 8480426
    [Abstract] [Full Text] [Related]

  • 20. Synthetic peptides allow discrimination of structural features of CD4(81-92) important for HIV-1 infection versus HIV-1-induced syncytium formation.
    Lifson JD, Rausch DM, Kalyanaraman VS, Hwang KM, Eiden LE.
    AIDS Res Hum Retroviruses; 1991 Jun 15; 7(6):521-7. PubMed ID: 1931230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.